Ascopiave Balance Sheet Health
Financial Health criteria checks 3/6
Ascopiave has a total shareholder equity of €857.8M and total debt of €417.9M, which brings its debt-to-equity ratio to 48.7%. Its total assets and total liabilities are €1.5B and €594.5M respectively. Ascopiave's EBIT is €53.8M making its interest coverage ratio 6.7. It has cash and short-term investments of €34.9M.
Key information
48.7%
Debt to equity ratio
€417.92m
Debt
Interest coverage ratio | 6.7x |
Cash | €34.94m |
Equity | €857.79m |
Total liabilities | €594.53m |
Total assets | €1.45b |
Recent financial health updates
Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt
Mar 08Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden
Sep 26Ascopiave (BIT:ASC) Seems To Use Debt Quite Sensibly
Mar 28Does Ascopiave (BIT:ASC) Have A Healthy Balance Sheet?
Nov 19Recent updates
Ascopiave S.p.A.'s (BIT:ASC) Popularity With Investors Is Under Threat From Overpricing
Apr 17Wind Farm Projects And EstEnergy Stake Sale Will Improve Future Prospects
Mar 09 Strategic restructuring and simplification may enhance operational efficiencies and net margins through mergers and acquisitions, particularly in renewable energy and gas distribution.News Flash: Analysts Just Made A Notable Upgrade To Their Ascopiave S.p.A. (BIT:ASC) Forecasts
Feb 16Solid Earnings Reflect Ascopiave's (BIT:ASC) Strength As A Business
Nov 17€3.05: That's What Analysts Think Ascopiave S.p.A. (BIT:ASC) Is Worth After Its Latest Results
Aug 02Ascopiave's (BIT:ASC) Upcoming Dividend Will Be Larger Than Last Year's
Apr 25Ascopiave's (BIT:ASC) Earnings Offer More Than Meets The Eye
Apr 07Ascopiave's (BIT:ASC) Shareholders Will Receive A Bigger Dividend Than Last Year
Mar 13Ascopiave (BIT:ASC) Takes On Some Risk With Its Use Of Debt
Mar 08Ascopiave (BIT:ASC) Is Paying Out Less In Dividends Than Last Year
Mar 11Ascopiave S.p.A.'s (BIT:ASC) Intrinsic Value Is Potentially 50% Above Its Share Price
Oct 20Here's Why Ascopiave (BIT:ASC) Has A Meaningful Debt Burden
Sep 26Need To Know: The Consensus Just Cut Its Ascopiave S.p.A. (BIT:ASC) Estimates For 2022
Aug 12Investors Could Be Concerned With Ascopiave's (BIT:ASC) Returns On Capital
Jun 14What Does Ascopiave S.p.A.'s (BIT:ASC) Share Price Indicate?
Mar 05Ascopiave (BIT:ASC) May Have Issues Allocating Its Capital
Oct 25Ascopiave (BIT:ASC) Might Be Having Difficulty Using Its Capital Effectively
Jul 20At €3.73, Is It Time To Put Ascopiave S.p.A. (BIT:ASC) On Your Watch List?
Jun 06Something To Consider Before Buying Ascopiave S.p.A. (BIT:ASC) For The 4.1% Dividend
Apr 13Ascopiave (BIT:ASC) Seems To Use Debt Quite Sensibly
Mar 28Ascopiave S.p.A. Just Beat EPS By 56%: Here's What Analysts Think Will Happen Next
Mar 14Here's What To Make Of Ascopiave's (BIT:ASC) Returns On Capital
Mar 01At €3.76, Is Ascopiave S.p.A. (BIT:ASC) Worth Looking At Closely?
Feb 15Can Ascopiave S.p.A.'s (BIT:ASC) Weak Financials Pull The Plug On The Stock's Current Momentum On Its Share Price?
Feb 02Shareholders Of Ascopiave (BIT:ASC) Must Be Happy With Their 134% Total Return
Jan 18Consider This Before Buying Ascopiave S.p.A. (BIT:ASC) For The 5.9% Dividend
Jan 03Does Ascopiave's (BIT:ASC) Statutory Profit Adequately Reflect Its Underlying Profit?
Dec 19How Much Of Ascopiave S.p.A. (BIT:ASC) Do Institutions Own?
Dec 05Does Ascopiave (BIT:ASC) Have A Healthy Balance Sheet?
Nov 19Financial Position Analysis
Short Term Liabilities: ASC's short term assets (€351.1M) exceed its short term liabilities (€214.7M).
Long Term Liabilities: ASC's short term assets (€351.1M) do not cover its long term liabilities (€379.8M).
Debt to Equity History and Analysis
Debt Level: ASC's net debt to equity ratio (44.6%) is considered high.
Reducing Debt: ASC's debt to equity ratio has increased from 33.1% to 48.7% over the past 5 years.
Debt Coverage: ASC's debt is well covered by operating cash flow (24.2%).
Interest Coverage: ASC's interest payments on its debt are well covered by EBIT (6.7x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/04/20 22:11 |
End of Day Share Price | 2025/04/17 00:00 |
Earnings | 2024/12/31 |
Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ascopiave S.p.A. is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Luigi De Bellis | Equita SIM S.p.A. |
Roberto Letizia | Equita SIM S.p.A. |
Monica Bosio | Intesa Sanpaolo Equity Research |